Recurrent missense mutation in the protoporphyrinogen oxidase gene underlies variegate porphyria

✍ Scribed by Frank, Jorge; Jugert, Frank K.; Breitkopf, Claudia; Goerz, G�nter; Merk, Hans F.; Christiano, Angela M.

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 17 KB
• Volume: 79
• Category: Article
• ISSN: 0148-7299
• DOI: 10.1002/(sici)1096-8628(19980827)79:1<22::aid-ajmg6>3.0.co;2-k

✦ Synopsis

The porphyrias represent a heterogeneous group of disorders of porphyrin or porphyrin-precursor metabolism, resulting from the inherited or acquired dysregulation of one of the eight enzymes in the porphyrinheme biosynthetic pathway. Variegate porphyria, one of the acute hepatic porphyrias, is characterized by a partial reduction in the activity of the penultimate enzyme in the heme biosynthetic pathway, protoporphyrinogen oxidase (PPO). Recently, VP has been linked to the PPO gene on chromosome 1q22-23, and several disease-causing mutations have been described. In this study, we identified the underlying genetic lesion in two unrelated patients with VP and investigated all available family members by polymerase chain reaction, heteroduplex analysis, automated sequencing, and restriction enzyme digestion. Mutation analyses in both families revealed a G-to-A transition in exon 6 of the PPO gene resulting in the substitution of arginine by histidine at position 168 of the protein (R168H). This arginine residue is evolutionarily conserved in human, mouse, and Bacillus subtilis, indicating the importance of this residue in PPO function. Our study establishes a recurrent missense mutation as the underlying genetic defect in two unrelated patients with VP and explains the occurrence of the phenotype in their families. Am.